HIV virology and pathogenetic mechanisms of infection: A brief overview

Annali dell'Istituto Superiore di Sanita

Volumn 46, Issue 1, 2010, Pages 5-14

  Fanales Belasio, Emanuele ^a   Raimondo, Mariangela ^a   SuligoI , Barbara ^a   Buttò, Stefano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Antigenic variation; HIV; Virulence; Virus replication

Indexed keywords

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENICITY; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE; VIROLOGY; VIRUS REPLICATION;

HIV; HIV INFECTIONS; HUMANS; VIRUS REPLICATION;

EID: 77949839798     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: 10.4415/ANN-10-01-02     Document Type: Review

References (63)

1. Luciw PA. Human immunodeficiency virus and their replication. In: Fields BN, Knippe DM, Howley PM (Ed.). Field virology. Philadelphia: Lippincott-Raven; 1996. p. 1881-1952
2. Lucas, SB, Hounnou A, Peacock C, Beaumel A, Djomand G, N'Gbichi JM, Yeboue K, Hondé M, Diomande M, Giordano C, Doorly R, Brattegaard K, Kestens L, Smithwick R, Kadio A, Ezani N, Yapi A, De Cock KM. The mortality and pathology of HIV infection in a west African city. AIDS 1993;7:1569-1579
3. Whittle H, Morris J, Todd J, Corrah T, Sabally S, Bangali J, Ngom PT, Rolfe M, Wilkins A. HIV-2-infected patients survive longer than HIV-1-infected patients. AIDS 1994;8:1617-1620
4. Gelderblom HR, Ozel M, Pauli G. Morphogenesis and morphology of HIV. Structure-function relations. Arch Virol 1989;106:1-13.
5. Emerman M, Malim M.H. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 1998;280:1880-1884
6. Weiss R.A. Cellular receptors and viral glycoproteins involved in retrovirus entry. In: Levy JA (Ed.). The Retroviridae (vol. 2). New York, USA: Plenum Press; 1993. p. 1-108.
7. Miceli MC, Parnes JR. Role of CD4 and CD8 in T cell activation and differentiation. Adv Immunol 1993;53:59-122.
8. Alkhatib G, Berger EA. HIV coreceptors: from discovery and designation to new paradigms and promise. Eur J Med Res 2007;12:375-384
9. Broder CC, Berger E. Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages. Proc Natl Acad Sci 1995;92:9004-9008
10. Coakley E, Petropoulos CJ, Whitcomb J.M. Assessing chemokine co-receptor usage in HIV. Cur Opin Infect Dis 2005; 18:9-15.
11. Garzino-Demo A. Chemokines and defensins as HIV suppressive factors: an evolving story. Curr Pharm Des 2007; 13:163-172
12. Chun TW, Carruth L, Finzi D, Shen X, Di Giuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano R.F. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997;387:183-188
13. Menéndez-Arias L. Targeting HIV: antiretroviral therapy and development of drug resistance. Trends Pharmacol Sci 2002;23:381-388
14. Sarafianos SG, Marchand B, Das K, Himmel DM, Parniak MA, Hughes SH, Arnold E. Structure and function of HIV-1 Reverse Transcriptase: molecular mechanisms of polymerization and inhibition. J Mol Biol 2009;385:693-713.
15. Ho D.D. Perspectives series: host/pathogen interactions. dynamics of HIV-1 replication in vivo. J Clin Invest 1997; 99:2565-2567
16. UNAIDS. 2008 Report on the global AIDS epidemic, UNAIDS. Available from: http://search.unaids.org/Results.aspx?d=en&q= report+on+global+aids+epidemic+2008&c=&l=en&s=f.
17. Peeters M, Gueye A, Mboup S, Bibollet-Ruche F, Ekaza E, Mulanga C, Ouedrago R, Gandji R, Mpele P, Dibanga G, Koumare B, Saidou M, Esu-Williams E, Lombart JP, Badombena W, Luo N, Vanden Haesevelde M, Delaporte E. Geographical distribution of HIV-1 group O viruses in Africa. AIDS 1997;11:493-498
18. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM, Hahn B.H. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436-441
19. Carr JK, Avila M, Gomez Carrillo M, Salomon H, Hierholzer J, Watanaveeradej V, Pando MA, Negrete M, Russell KL, Sanchez J, Birx DL, Andrade R, Vinoles J, McCutchan F.E. Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 2001;15:F41-7.
20. Suligoi B, Raimondo M, Fanales-Belasio E, Buttò S. The epidemic of HIV infection and AIDS, promotion of testing, and innovative strategies. Ann Ist Super Sanità 2010;46:15-23.
21. Martin N, Sattentau Q. Cell-to-cell HIV-1 spread and its implications for immune evasion. Curr Opin HIV AIDS 2009; 4:143-149
22. Lekkerkerker AN, van Kooyk Y, Geijtenbeek TB. Viral piracy: HIV-1 targets dendritic cells for transmission. Curr HIV Res 2006;4:169-176
23. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-362
24. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-358
25. Alexaki A, Liu Y, Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res 2008;6:388-400.
26. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch M.P. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003;17:1871-1879
27. Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 1997;102:117-124
28. Ling AE, Robbins KE, Brown TM, Dunmire V, Thoe SY, Wong SY, Leo YS, Teo D, Gallarda J, Phelps B, Chamberland ME, Busch MP, Folks TM, Kalish ML. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. JAMA 2000;284:210-214
29. Kopko PM, Fernando LP, Bonney EN, Freeman JL, Holland P.V. HIV transmissions from a window-period platelet donation. Am J Clin Pathol 2001;116:562-566
30. Lindbäck S, Thorstensson R, Karlsson AC, von Sydow M, Flamholc L, Blaxhult A, Sönnerborg A, Biberfeld G, Gaines H. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS 2000;14:2333-2339
31. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn J.O. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002;16:1119-1129
32. Holodniy M, Busch M. Establishing the diagnosis of HIV infection. In: Dolin R, Masur H, Saag M (Ed.). AIDS therapy. 2nd. New York: Churchill Livingstone (Elsevier); 2002. p. 3-20.
33. Nguyen KA, Busch M.P. Evolving strategies for diagnosing human immunodeficiency virus infection. Am J Med 2000;109:595-597
34. Little SJ, McLean AR, Spina CA, Richman DD, Havlir D.V. Viral dynamics of acute HIV-1 infection. J Exp Med 1999;190:841-850
35. Kahn JO, Walker B.D. Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998;339:33-39
36. Bangham C.R. CTL quality and the control of human retroviral infections. Eur J Immunol 2009;39:1700-1712
37. Koup R.A. Virus escape from CTL recognition. J Exp Med 1994;180:779-782
38. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone M.B. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-6110
39. Price DA, Goulder PJ, Klenerman P, Sewell AK, Easterbrook PJ, Troop M, Bangham CR, Phillips R.E. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 1997;94:1890-1895
40. Allen TM, O'Connor DH, Jing P, Dzuris JL, Mothé BR, Vogel TU, Dunphy E, Liebl ME, Emerson C, Wilson N, Kunstman KJ, Wang X, Allison DB, Hughes AL, Desrosiers RC, Altman JD, Wolinsky SM, Sette A, Watkins D.I. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 2000;407:386-390
41. Buttò S, Raimondo M, Fanales-Belasio E, Suligoi B. Suggested strategies for the laboratori diagnosis of HIV infection in Italy. Ann Ist Super Sanità 2010;46:34-41.
42. Buttò S, Suligoi B, Fanales-Belasio E, Raimondo M. Laboratory diagnostics for HIV infection. Ann Ist Super Sanità 2010;46:24-33.
43. Weber B. Screening of HIV infection: role of molecular and immunological assays. Expert Rev Mol Diagn 2006;6:399-411.
44. Vanhems P, Lambert J, Cooper DA, Perrin L, Carr A, Hirschel B, Vizzard J, Kinloch-de Loës S, Allard R. Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship. Clin Infect Dis 1998;26:323-329
45. Pedersen C, Nielsen JO, Dickmeis E, Jordal R. Early progression to AIDS following primary HIV infection. AIDS 1989;3:45-47
46. Keet IP, Krijnen P, Koot M, Lange JM, Miedema F, Goudsmit J, Coutinho R.A. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993;7:51-57
47. Gupta K.K. Acute immunosuppression with HIV seroconversion. N Engl J Med 1993;328:288-289
48. Rosenberg YJ, Anderson AO, Pabst R. HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking? Immunol Today 1998;19:10-17
49. Lichterfeld M, Kaufmann DE, Yu XG, Mui SK, Addo MM, Johnston MN, Cohen D, Robbins GK, Pae E, Alter G, Wurcel A, Stone D, Rosenberg ES, Walker BD, Altfeld M. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med 2004;200:701-712
50. Douek DC. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev 2003;5(3):172-177
51. Lange CG, Lederman MM, Medvik K, Asaad R, Wild M, Kalayjian R, Valdez H. Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection. AIDS 2003;17:2015-2023
52. Ford ES, Puronen CE, Sereti I. Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm. Curr Opin HIV AIDS 2009;4:206-214
53. Stamatatos L, Morris L, Burton DR, Mascola JR. Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat Med 2009;15:866-870
54. Chung A, Rollman E, Johansson S, Kent SJ, Stratov I. The utility of ADCC responses in HIV infection. Curr HIV Res 2008;6:515-519
55. Baker BM, Block BL, Rothchild AC, Walker B.D. Elite control of HIV infection: implications for vaccine design. Expert Opin Biol Ther 2009;9:55-69.
56. Saksena NK, Rodes B, Wang B, Soriano V. Elite HIV controllers: myth or reality? AIDS Rev 2007;9:195-207.
57. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, Douek DC. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004;200:749-759
58. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, Markowitz M. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004;200:761-770
59. Brooks JT, Kaplan JE, Holmes KK, Benson C, Pau A, Masur H. HIV-associated opportunistic infections-going, going, but not gone: the continued need for prevention and treatment guidelines. Clin Infect Dis 2009;48:609-611
60. Clifford GM, Franceschi S. Cancer risk in HIV-infected persons: influence of CD4(+) count. Future Oncol 2009; 5:669-678
61. Piacentini L, Biasin M, Fenizia C, Clerici M. Genetic correlates of protection against HIV infection: the ally within. J Intern Med 2009;265:110-124
62. Letvin NL. Correlates of immune protection and the development of a human immunodeficiency virus vaccine. Immunity 2007;27:366-369
63. International AIDS Vaccine Initiative (IAVI). AIDS Vaccine Blueprint 2008: A Challenge to the Field, A Roadmap for Progress. IAVI (August 2008). Available from: www.iavi.org/Lists/IAVIPublications/attachments/750bc28e-0e47- 4a1e-91bf-eeea7c8bb98e/IAVI-AIDS-Vaccine-Blueprint-2008-ENG.pdf.